Reply: People living with HIV and NAFLD and updated guidance on NAFLD screening

Affiliations

Comment

Mary E Rinella et al. Hepatology. 2023.

. 2023 Nov 1;78(5):E91-E92.

doi: 10.1097/HEP.0000000000000469. Epub 2023 May 22.

No abstract available

Comment on

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, Kleiner DE, Loomba R. Rinella ME, et al. Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17. Hepatology. 2023. PMID: 36727674 Free PMC article. No abstract available.
Letter to the Editor: People living with HIV and NAFLD-A population left behind in the global effort for liver fibrosis screening?
Sebastiani G, Milic J, Tsochatzis EA, Marzolini C, Betel M, Bhagani S, Morse CG, Cinque F, Maurice JB, Ingiliz P, Price J, Lemoine M, Rockstroh JK, Guaraldi G; Steatohepatitis in HIV Emerging Research (SHIVER) Network. Sebastiani G, et al. Hepatology. 2023 Nov 1;78(5):E87-E88. doi: 10.1097/HEP.0000000000000465. Epub 2023 May 19. Hepatology. 2023. PMID: 37199181 No abstract available.
Letter to the Editor: Updated guidance on NAFLD screening.
Arias-Loste MT, Crespo J, Iruzubieta P. Arias-Loste MT, et al. Hepatology. 2023 Nov 1;78(5):E89-E90. doi: 10.1097/HEP.0000000000000462. Epub 2023 May 19. Hepatology. 2023. PMID: 37199219 No abstract available.

1. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797–1835.
1. Tamaki N, Ahlholm N, Luukkonen PK, Porthan K, Sharpton SR, Ajmera V, et al. Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease. J Clin Invest. 2022;132:e162513.
1. Rodriguez-Duque JC, Calleja JL, Iruzubieta P, Hernández-Conde M, Rivas-Rivas C, Vera MI, et al. Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors. Clin Gastroenterol Hepatol. 2023;21:406–414.
1. Bellinato F, Gisondi P, Mantovani A, Girolomoni G, Targher G. Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies. J Endocrinol Invest. 2022;45:1277–1288.
1. Durán-Vian C, Arias-Loste MT, Hernández JL, Fernández V, González M, Iruzubieta P, et al. High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors. J Eur Acad Dermatol Venereol. 2019;33:2131–2136.